Suggestions
Dušan Stojanović
Founding Partner and Director at True Global Ventures 4 Plus
Dušan Stojanović is a Founding Partner and Director at True Global Ventures, based in Singapore.1 He holds several board positions across various companies, including:
- Observer Board Member at Chronicled (since February 2022)
- Board Member at GCEX (since January 2022)
- Board Member at ChromaWay (since January 2022)
- Board Member at IKONIA (since November 2021)
- Board Member at The Sandbox (since September 2019)1
Stojanović has been involved with True Global Ventures since its inception, serving as Founder and Director since October 2010.1 His experience spans across multiple locations, including Silicon Valley, New York, Singapore, Hong Kong, Beijing, London, Berlin, Paris, and Stockholm.1
Regarding his education, Stojanović holds a Master's degree from the University of Gothenburg, which he obtained between 1990 and 1994.1 He is proficient in several languages, including Swedish, German, French, and English.1
It's important to note that while Stojanović is listed as an Observer Board Member at Chronicled, there is no specific mention of him being an Observer Board Member at Ledger in the provided search results.
Highlights
A big congratulations to our portfolio company, Chronicled, on their remarkable achievement! Chronicled's innovative MediLedger Network is continuing to revolutionize contract management and ensure accurate pricing across extensive health systems network. We're thrilled to see Prisma Health, South Carolina’s largest health organization, join other leading health systems, including OSF HealthCare and Baptist Health System KY & IN, on the MediLedger network.
The pain point Chronicled's Mediledger is addressing for Prisma is succinctly depicted by Jennifer Bair, PharmD, MBA, BCPS, Vice President, Pharmacy Services and Chief Pharmacy Officer of Prisma Health: “With a vast network of healthcare facilities and a substantial inventory of pharmaceuticals, Prisma Health was in need of a solution that could simplify communication lines and guarantee that we receive the correct negotiated prices for pharmaceutical products promptly...”
And the solution with Mediledger: “The current manual processes are time-consuming and often lead to errors and cash flow issues. MediLedger’s blockchain solution will enable us to collaborate in real-time with group purchasing organizations, manufacturers, and wholesalers, identifying and addressing pricing discrepancies before they impact our operations.”
This is a significant step forward in setting new standards for trust and accuracy in the healthcare industry. We are incredibly proud to support Chronicled on their journey and can't wait to see their continued growth and success.
👏 Kudos to the entire Chronicled team for this well-deserved recognition! Maurizio Greco Haris Kamal Eric Garvin David Aho Matthew Immerso Rick Perry
https://lnkd.in/gEsD5eUy
#Innovation #HealthcareTechnology #Pharma #Blockchain #SupplyChain
🚀 Exciting news from our TGV Portofolio company Forge ! In Q2 2024, the company saw a 15% QoQ and 32% YoY increase in revenue to $22 million, driven by better market conditions and their new Data Analytics/AI strategy with Forge PRO, launched at the end of Q1. Marketplace revenues soared by 35% QoQ, and trading volume surged by 62% QoQ to $426.3 million. Forge Global also implemented cost-cutting measures of 11% as its data analytics/AI strategy starts to deliver higher productivity impacting the bottom line.
This is a significant improvement from last quarter. 🌟
on May 28th this year, we had the pleasure to welcome Forge Global as co-organiser of our True Global Ventures 4th AI Global Competition. Congrats to the entire Forge team including Kelly Rodriques Eric Thomassian and Jennifer Phillips.
Join us on this journey of profitable innovation and success!
#ForgeGlobal #FinancialGrowth #Innovation #AI #Productivity
Read more:
